RTC not the end game21 Jun 2020 01:16
Wow my socks are blown off by ODX's involvement with Mologic. Both Antigen and Antibody, this is really significant. Plus look at how much capital is being used on developing Meningitis and TB tests in HIV patients . This company is truly in a transformational stage. Its a long hold for me , post Covid is going to be fascinating with ODX. This is once in a lifetime opportunity for a small biotech company and although Covid has been attrocious its has brought a jackpot of cash into the biotech sector which will benefit research into other awful medical conditions. Exciting times in biotech.